← All diseases Infectious diseases

Drug-resistant tuberculosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (60)Meta-analysis (18)Treatment guideline (2)Phase 3 study (14)Systematic review (13)Randomized controlled trial (13)Clinical trial (160)Review article (219)Early Study (Phase 1 or 2) (10)Case report (62)Laboratory or animal study (27)Commentary or editorial (27)Retracted publication (1) Studies currently recruiting participants only (23)

Filter

Publications and studies (1454)

• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. State of the global tuberculosis epidemic: burden, progress towards WHO End TB Strategy targets and systemic challenges. (2027/04/26) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in development of tuberculosis vaccines and preventive drug therapies: current pipeline, evidence, and access. (2027/04/26) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in tuberculosis treatment: novel regimens, new drug pipelines, host-directed therapies, and updated management guidelines. (2027/04/26) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Different MicroRNAs expression in Mycobacterium tuberculosis and correlation with prognosis of the disease. (2026/12/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Time to sputum culture conversion and its predictors among drug-resistant tuberculosis patients in Ethiopia: a systematic review and meta-analysis. (2026/09/01) ♡
• [Chinese expert consensus on the diagnosis and treatment of pneumoconiosis complicated with tuberculosis]. (2026/08/12) ♡
• Molecular insights into inhibitor action on the catalytic activity of Mycobacterium tuberculosis cystathionine β-synthase enzyme. (2026/08/10) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. What is new in Tuberculosis? (2026/08/10) ♡
• The Natural Product Corramycin Acts as a DNA Gyrase Poison and Overcomes Fluoroquinolone Resistance in Mycobacterium tuberculosis. (2026/08/10) ♡
• Catalysing tuberculosis elimination in Indonesia: Health economic and policy insights from the BPaL regimen. (2026/08/07) ♡
• One-Arrow-Three Hawks: Antibiotic-Derived Nanozybiotics with Retained Antibacterial Activity and Dual Peroxidase-/Catalase-like Nanozyme for Potential ROS Modulation. (2026/08/07) ♡
• Development and Internal Validation of a Clinical Risk Score for Loss to Follow-Up Among Drug-Resistant Tuberculosis Patients in a High-Burden Setting, Ethiopia: A Multicenter Retrospective Study. (2026/08/07) ♡
• Boron-Containing Drug Candidates in Clinical Trials. (2026/08/06) ♡
• Assessment of financial protection mechanisms for tuberculosis services in seven priority countries of the Western Pacific Region: a cross-sectional mixed-methods study. (2026/08/06) ♡
• Clinical guideline highlights for the hospitalist: Updates on the treatment of drug-susceptible and drug-resistant tuberculosis. (2026/08/05) ♡
• Structural insights into multitargeting Mycobacterium tuberculosis Pkn kinases. (2026/08/04) ♡
• Rapid detection of treatment-emergent resistance to bedaquiline and pretomanid in Mycobacterium tuberculosis using TM4::GeNL reporter mycobacteriophages. (2026/08/04) ♡
• Trends and Characteristics of Drug-Resistant Tuberculosis: A Five-Year Study at a Major Specialized Hospital in Guizhou, China (2018-2023). (2026/08/04) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Mycobacterium marinum as a surrogate model for tuberculosis pathogenesis and drug discovery. (2026/08/04) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advancing Therapies for Mycobacterial Diseases: From Small Molecules to Host-Directed Strategies. (2026/08/04) ♡
• Design, synthesis and antitubercular evaluation of 2,5-disubstituted 1,3,4-oxadiazoles bearing a 3,5-dinitrophenyl pharmacophore. (2026/08/04) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Europe's failure to deliver on drug-resistant tuberculosis. (2026/08/03) ♡
• A model for the epidemiological impact of tuberculosis policy options. (2026/08/01) ♡
• Analytical Method Development and Validation for Clofazimine in Human Plasma and Application of LC-MS/MS Based Methods for Clofazimine and Bedaquiline in Indian MDR-TB Patients Stratified by HIV Coinfection. (2026/08/01) ♡
• Exploring the Antitubercular, Antimicrobial Potency, ADME-T Calculations and Docking Studies of 1,2,4-Triazole-Bearing Benzimidazoles. (2026/08/01) ♡
• Synthesis, Characterization, and Inhibitory Potential of Fagonia arabica L. Phytochemicals Coated Gold Nanoparticles Against Drug-Resistant Mycobacterium tuberculosis. (2026/08/01) ♡
• Truenat MTB Plus Assay for Diagnosing Extrapulmonary Tuberculosis and Detecting Resistance to Rifampicin and Isoniazid. (2026/08/01) ♡
• Biochemical characterization and assay development for adenylosuccinate synthetase Rv0357c from Mycobacterium tuberculosis. (2026/07/31) ♡
• Successful Use of Infliximab and a Shortened Antibiotic Regimen in Pediatric Multidrug-resistant Tuberculous Meningitis With Paradoxical Reactions. (2026/07/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Quadruple co-infection with Mycobacterium tuberculosis complex and M. kansasii in a chronically immunosuppressed cat. (2026/07/29) ♡
• Detection of drug-resistant Extrapulmonary tuberculosis by Xpert® MTB/XDR assay - a comparison with phenotypic drug susceptibility testing and line probe assay. (2026/07/29) ♡
• Applying Pharmaceutical Care Concepts to Address Antimicrobial Resistance in Low- and Middle-Income Countries with Particular Emphasis on Tuberculosis. (2026/07/29) ♡
• Genomic diversity and transmission routes of Mycobacterium tuberculosis isolates in Morocco. (2026/07/29) ♡
• Cerebrospinal Fluid Concentrations of Bedaquiline, Pretomanid, and Linezolid During Curative Treatment of Fluoroquinolone-Resistant Pre-Extensively Drug-Resistant Tuberculous Meningitis. (2026/07/29) ♡
• Pharmacokinetics and safety of TBAJ-587, a novel antimycobacterial diarylquinoline, in healthy participants. (2026/07/28) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Nurses' roles in facilitating parental involvement in pediatric tuberculosis care: A scoping review. (2026/07/28) ♡
• Discordant Rifampicin Resistance Results in Repeat Xpert MTB/RIF Testing: Risk Factors and Diagnostic Challenges Among Drug-Resistant Tuberculosis Patients in Bangladesh. (2026/07/28) ♡
• A Decade of Unfavorable Outcomes in Pulmonary Tuberculosis: Proportion and Factors Associated in Kelantan, Malaysia. (2026/07/28) ♡
• Discovery and Mechanism of Action of a Novel Desloratadine Derivative Inhibiting Mycobacterium tuberculosis 3-Dehydroquinate Synthase. (2026/07/27) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Mycobacterium intracellulare M.i.198-A Promising Strain for Studying Pathogenesis of Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD). (2026/07/27) ♡
• Transcriptional Profiling of Hypo- and Hypervirulent Mycobacterium tuberculosis Isolates Characterised by Differential Expression of the Moa3 Operon. (2026/07/27) ♡
• Rapid Extensively Drug-Resistant (XDR) TB Diagnosis: An In-House DNA Biochip for Drug Resistance Detection and Mutation Profiling of Mycobacterium tuberculosis. (2026/07/27) ♡
• Correction to: Pregnant Women With Multidrug-Resistant/Rifampicin-Resistant Tuberculosis and the All-Oral 6-Month Regimen: Experiences From a Patient Series in South Africa. (2026/07/25) ♡
• Modern Trends in the Development of Natural and Synthetic Anti-Tuberculosis Drugs. (2026/07/25) ♡
• Catastrophic Costs and Impoverishment Among Tuberculosis-Affected Households in Nepal: Results from a National Patient Cost Survey. (2026/07/24) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Screening and tuberculosis preventive treatment among household contacts of drug-resistant tuberculosis patients: a scoping review. (2026/07/24) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Atypical mycobacterial infection at laparoscopic port site: Report of two cases indicating possibility of multi drug resistant strains in north-east India and review of literature. (2026/07/24) ♡
• Cost-effectiveness of BPaL-based and 9-month modified all-oral short treatment regimens for rifampicin-resistant tuberculosis in Belarus. (2026/07/23) ♡
• National genomic survey of drug-resistance and multi-jurisdictional clusters of Mycobacterium tuberculosis in Australia 2015-2023. (2026/07/23) ♡
• Rifabutin Cross-resistance and Associated rpoB Mutations in Rifampicin-resistant Mycobacterium tuberculosis Complex Isolates. (2026/07/22) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.